ArticleThe journal of vascular access2026
A GAVeCeLT bundle for chest-port insertion: The SIC-Port protocol.
Article in The journal of vascular access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The insertion of totally implantable venous access devices (ports) is a procedure widely used in clinical practice. Ports are generally used in cancer patients undergoing chemotherapy and in patients who require long-term, infrequent access (less than once a week). Over the past four decades, ports have been inserted primarily by direct cannulation of the deep veins of the supra/infra-clavicular area, with subcutaneous placement of the reservoir over the pectoralis major muscle (so-called "thoracic port" or "chest-port"). This paper describes an insertion bundle-developed by GAVeCeLT, the Italian Group of Long-Term Venous Access Devices, and nicknamed "SIC-Port" (Safe Insertion of Chest-Port)-which consists of few evidence-based strategies aiming to further minimize all immediate, early, or late complications potentially associated with chest-port insertion. The SIC-Port bundle is currently adopted by all training courses on chest-port insertion held by GAVeCeLT. It includes eight steps: (1) systematic ultrasound evaluation of the supra/infra-clavicular veins according to the Rapid Central Venous Assessment (RaCeVA) protocol, thus choosing the most appropriate vein, in terms of caliber, site, depth, safety of venipuncture, and ease of tunneling; (2) appropriate hand hygiene, proper skin antisepsis, and maximal barrier precautions; (3) ultrasound-guided cannulation of the best available vein, with preference for the axillary vein (if adequate), so to avoid tunneling above the clavicle; (4) ultrasound control of the pleura, to exclude pneumothorax; (5) ultrasound-guided tip navigation; (6) intra-procedural assessment of tip location by intracavitary ECG and/or trans-thoracic echocardiography with bubble test; (7) appropriate creation of the subcutaneous pocket over the muscle; (8) appropriate closure of the subcutaneous pocket.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.